semaglutide covered by medi cal Medi-Cal should cover GLP-1 medications to treat obesity Semaglutide (GLP-1) for Medical Weight

The effect of blood pressure reduction from such medications at standard dose has been estimated to lower the risk of coronary heart disease events by about one-quarter and the risk of stroke by about one-third (108)

Care 4, 279285

So while they contain the same medication, they are not interchangeable each brand is approved for different primary uses, may be intended for different patient populations, and follows different dosing regimens based on its specific FDA-approved indication

Xue H, Ren W, Denkinger M, Schlotzer E, Wischmeyer PE

These criteria help researchers focus on individuals who may benefit most from GLP-1 medications

Gut bless you: the microbiota-gut-brain axis in irritable bowel syndrome